HillSide Lawn Service Launches Spring Lawn Care Programs Across Mid-Atlantic Region
"Early spring treatments set the stage for a healthy lawn all season," said
Founded in 1994, HillSide's soil analysis and systematic approach has proven successful in developing dense, disease-resistant lawns that naturally suppress weed growth. All three service packages incorporate products that comply with nutrient management laws supporting
The company's commitment to environmental stewardship is evident in its use of Department of Agriculture licensed Enhanced Efficiency Fertilizer (EEF), which provides sustained nutrition while protecting local waterways. HillSide's team of Certified Professional Agronomists (CPAg) have over 150 years combined experience, and are dedicated to creating green, healthy properties across the tri-state area.
HillSide attributes its rapid growth to its personalized service model. Each customer is assigned a dedicated technician with detailed expertise in local soil conditions and turf varieties. "Our residential customers value seeing the same friendly face care for their property each time," said
Homeowners and commercial businesses interested in starting their spring lawn care program are encouraged to contact HillSide by
About HillSide Lawn Service:
Since 1994, HillSide Lawn Service has offered expert lawn care, including aeration and over-seeding and tree and shrub care. With a focus on sustainable, science-based methods and personalized service, HillSide is the trusted source for creating green, healthy lawns throughout
Media Contact:
[email protected]
410-366-9479 x101
View original content to download multimedia:https://www.prnewswire.com/news-releases/hillside-lawn-service-launches-spring-lawn-care-programs-across-mid-atlantic-region-302372443.html
SOURCE HillSide Lawn Service
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
- Solution Financial Reports Q2 2026 Financial Results
- Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share